Ghent University Academic Bibliography

Journal Article
A1
open access

Human immunity and susceptibility to influenza A(H3) viruses of avian, equine, and swine origin

Elien Vandoorn (UGent) , Wojciech Stadejek (UGent) , Isabel Leroux-Roels (UGent) , Geert Leroux-Roels (UGent) , Anna Parys (UGent) and Kristien Van Reeth (UGent)

(2023) EMERGING INFECTIOUS DISEASES. 29(1). p.98-109

Add to list

Journal Article
A1
open access

Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine

Isabel Leroux-Roels (UGent) , Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Jasper Joye (UGent) , Cathy Maes, Paul-Henri Lambert and Geert Leroux-Roels (UGent)

(2023) VACCINES. 11(2).

Add to list

Journal Article
A1
open access

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

Rani Burm (UGent) , Freya Van Houtte (UGent) , Lieven Verhoye (UGent) , Ahmed Atef Ahmed Abouzeid Mesalam (UGent) , S Ciesek, P Roingeard, H Wedemeyer, Geert Leroux-Roels (UGent) and Philip Meuleman (UGent)

(2023) JHEP REPORTS. 5(3).

Add to list

Journal Article
A1
open access

Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant

Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Bart Jacobs (UGent) , Franziska Jarczowski, André Diessner, Geert Leroux-Roels (UGent) , Victor Klimyuk, Isabel Leroux-Roels (UGent) and Frank Thieme

(2023) FRONTIERS IN IMMUNOLOGY. 14.

Add to list

Journal Article
A1
open access

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine

Isabel Leroux-Roels (UGent) , Cathy Maes, Jasper Joye (UGent) , Bart Jacobs (UGent) , Franziska Jarczowski, André Diessner, Yorick Janssens (UGent) , Gwenn Waerlop (UGent) , Kirsi Tamminen, Suvi Heinimäki, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.

Add to list

Journal Article
A1
open access

Characterization of the cell-mediated immune response to Takeda’s live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting

Vianney Tricou, Raphael Gottardo, Michael A. Egan, Frédéric Clement (UGent) , Geert Leroux-Roels (UGent) , Xavier Sáez-Llorens, Astrid Borkowski, Derek Wallace and Hansi J. Dean

(2022) VACCINE. 40(8). p.1143-1151

Add to list

Journal Article
A1
open access

The role of cell-mediated immunity against influenza and its implications for vaccine evaluation

Yorick Janssens (UGent) , Jasper Joye (UGent) , Gwenn Waerlop (UGent) , Frédéric Clement (UGent) , Geert Leroux-Roels (UGent) and Isabel Leroux-Roels (UGent)

(2022) FRONTIERS IN IMMUNOLOGY. 13.

Add to list

Journal Article
A1
open access

Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium

Gwenn Waerlop (UGent) , Geert Leroux-Roels (UGent) , Teresa Lambe, Duncan Bellamy, Donata Medaglini, Elena Pettini, Rebecca Jane Cox, Mai-Chi Trieu, Richard Davies, Geir Bredholt, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.

Add to list

Journal Article
A1
open access

Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity and safety of OVX836, a nucleoprotein-based influenza vaccine

Isabel Leroux-Roels (UGent) , Gwenn Waerlop (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Catherine Maes (UGent) , Jacques Bruhwyler, Delphine Guyon-Gellin, Philippe Moris, Judith Del Campo, Paul Willems, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.

Add to list

Journal Article
A1
open access

Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium

Sarah Begue, Gwenn Waerlop (UGent) , Bruno Salaun, Michel Janssens, Duncan Bellamy, Rebecca Jane Cox, Richard Davies, Elena Gianchecchi, Donata Medaglini, Emanuele Montomoli, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.

Academic Bibliography

Human immunity and susceptibility to influenza A(H3) viruses of avian, equine, and swine origin

Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection

Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine

Characterization of the cell-mediated immune response to Takeda’s live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting

The role of cell-mediated immunity against influenza and its implications for vaccine evaluation

Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium

Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity and safety of OVX836, a nucleoprotein-based influenza vaccine

Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium

Contents

Support

Contact